With approximately 30,000 sq. Mosaic Technologies, a biotechnology platform company was founded in 1994 and moved into the Photonics incubator shortly after. In October 1996 it signed an agreement with the Center to co-develop a second generation product combining the Center s expertise in photonics and product development with one of Mosaic's first generation products. With the participation of the Photonics Center s technical staff, Mosaic developed two prototype instruments to rapidly analyze blood samples for the presence of seven different pathogens. In early 1998, Mosaic began selling its first product, Acrodyte TM .
Every business partnership is unique and tailored to the individual company.
In this instance, the company had commercially significant technology which we complemented with the Center s technical expertise, physical infrastructure, equipment, incubator space, administrative, and business support necessary to move the technology from the laboratory demonstration phase to an actual prototype product. In return the Photonics Center has an equity share in the company and a royalty agreement on the sale of future products. About the Boston University Photonics Center The Photonics Center, a new model for university-industry collaboration, was launched by Boston University in 1994 to bridge the gap between basic research and practical application. Its mission is to forge true business partnerships with investors and industrial partners, turning emerging concepts in photonics technology into commercial products, and spawning a growing stream of new companies. Founded in 1994 to exploit a solid phase DNA chemistry invented at MIT, the company built an impressive inventory of intellectual property and created a plan that will achieve significant revenues in the clinical diagnostic and genomic research markets.